The combined use of HCC stiffness and AFP level provided high diagnostic accuracy in detecting GPC3 expression and could be considered a viable biomarker for identifying GPC3-positive HCC and predicting therapeutic outcome. Here, GPC3 is linked to hepatocellular carcinoma.